Security Stock News: TraceSafe (CSE: TSF) Joins Future Borders Coalition, Supports COVID-19 Recovery as a Leader in Tech Innovation
Vancouver, British Columbia - April 12, 2021 (Newsfile Corp.) (Investorideas.com Newswire) Tracesafe Inc. (CSE: TSF) ("TraceSafe"), a global leader in wearable safety tech and connected workforce solutions

AI Biometric Stock News: GBT (OTCPINK: GTCH) Filed a Nonprovisional patent for Systems and Methods of Facial and Body Recognition, identification and analysis
SAN DIEGO - March 30, 2021 (Investorideas.com Newswire) GBT Technologies Inc. (OTCPINK: GTCH) ("GBT", or the "Company") with GBT Tokenize Corp. ("GBT/Tokenize") filed with U.S. Patent and Trademark Office ("USPTO") a nonprovisional patent for systems and methods of facial and body recognition identification and analysis.

Biotech Stock News: Immunic, Inc. (NASDAQ: IMUX) Reports Year End 2020 Financial Results and Highlights Recent Activity
NEW YORK - February 26, 2021 (Investorideas.com Newswire) Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced financial results for the year ended December 31, 2020 and highlighted recent activity.

Security Stock News: Zedcor Inc. (TSXV: ZDC) Signs 21-Month, $1.8 Million Agreement with a Construction Partnership to Provide Hybrid MobileyeZ Security Towers
Calgary, Alberta - February 17, 2021 (Newsfile Corp.) (Investorideas.com Newswire) Zedcor Inc. (TSXV: ZDC) (the "Company" or "Zedcor"), a leading provider of strategic security solutions and remote video surveillance systems, is pleased to announce that it has entered into a rental and service agreement with a large engineering and construction joint venture (the "JV").

AI / Security Stock News: GBT (OTCPINK: GTCH) Filed Patent Application for AI Based Facial Recognition Security System
SAN DIEGO - February 16, 2021 (Investorideas.com Newswire) GBT Technologies Inc. (OTCPINK: GTCH) ("GBT", or the "Company") with GBT Tokenize Corp. ("GBT/Tokenize") filed with U.S. Patent and Trademark Office ("USPTO") a patent for AI facial recognition system, for computers and mobile devices.

Security Stock News: Plymouth Rock (CSE: PRT) (OTCQB: PLRTF) Accelerates Weapon Detection Radar to Assist United States Government Security
Plymouth, Massachusetts - February 9, 2021 (Newsfile Corp.) (Investorideas.com Newswire) Plymouth Rock Technologies Inc. (CSE: PRT) (OTCQB: PLRTF) (FSE: 4XA) (WKN: A2N8RH) ("Plymouth Rock", "PRT", or the "Company") a leader in developing threat detection and unmanned technologies, is pleased to announce that its CODA-1(Cognitive Object Detection Apparatus) system has undergone further successful testing for detection of various concealed weaponry on a person at our PRT laboratories.

HomelandDefenseStocks.com Q&A Interview with Scott Sacknoff, SPADE Defense Index ( $DXS) - Themes for Investors in 2021
Point Roberts, WA and Delta, BC - February 2, 2021 (Investorideas.com Newswire)Investorideas.com, a global news source and leading investor resource releases an exclusive Q&A interview through its defense portal HomelandDefenseStocks.com.

Investor Ideas Podcast Corner - Chairman, CEO of Sigyn Therapeutics, Inc. (OTC:$SIGY) Discusses Treatment of Life-Threatening Conditions Induced by Cytokine Storm Syndrome
Point Roberts, WA and Delta, BC - January 25, 2021 (Investorideas.com Newswire) Investorideas.com, a global news source and leading retail investor and trader resource issues a new CEO interview for the Podcast Corner. In today's special edition, Investor Ideas talks to Sigyn Therapeutics, Inc. (OTCMarkets: SIGY) Chairman and CEO, Jim Joyce.

Boeing Aircraft Sales Plummet 59% in 2020, Lowest in Nearly 50 Years
January 21, 2021 (Investorideas.com Newswire) The year 2020 was one of the worst years for Boeing’s aircraft sales.

Biotech Stock News: Novavax (NASDAQ: NVAX) Finalizes Agreement with Commonwealth of Australia for 51 Million Doses of COVID-19 Vaccines
Gaithersburg, Md. - January 8, 2021 (Investorideas.com Newswire) Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it has executed an Advance Purchase Agreement with the Commonwealth of Australia for 51 million doses of NVX-CoV2373, Novavax' COVID-19 vaccine candidate.